Clinical studies recruiting near Jiamusi

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277 Clinical Multimodal Surveillance of Respiratory Syndrome Pathogens
Phase N/A · Jiamusi Central Hospital · Huashan Hospital · NCT07694648 A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in Fi
Phase 3 · Jiamusi Cancer Hospital · Amgen · NCT07005128 Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation
NA · The Hongda Hospital of Jiamusi University · Capital Medical University · NCT07139301 Clinical Study on the Efficacy and Safety of LM-302 Injection Combined With Tislelizumab and Tislelizumab Combined Chemo
Phase 3 · Jiamusi Tuberculosis Hospital (Jiamusi Cancer Hospital) · Shanghai Chia Tai Tianqing Pharmaceutical Technology Develop · NCT07385703 Remote Ischemic Conditioning for Acute Ischemic Stroke Treated With Mechanical Thrombectomy（RECAST-MT）
Phase 3 · The Hongda Hospital of Jiamusi University · Capital Medical University · NCT06559241 Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic N
Phase 3 · Research Site · AstraZeneca · NCT07291037 A Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2)
Phase 3 · Jiamusi Cancer Hospital · Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharm · NCT07043725 Non-stenting Treatment Strategy for Acute Myocardial Infarction With Non-severe Stenosis(EROSION IV)
NA · Central Hospital of Jiamusi City · Harbin Medical University · NCT07567625 A Study to Assess the Effectiveness of Trastuzumab Deruxtecan in Chinese Breast Cancer Patients (REFRESH)
Phase N/A · Jiamusi Cancer Hospital · Daiichi Sankyo · NCT06210776 Art Therapy and Its Effect on Motor Function Rehabilitation in the Subacute Phase of Stroke Recovery
NA · Fuyuan People's Hospital · Chonbuk National University · NCT06709950 Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation 2
NA · The Hongda Hospital of Jiamusi University · Capital Medical University · NCT07139314 Treatment of Acute Ischemic StroKe With Intravenous UroKinase Real-world Research: a Multicenter, Prospective Study
Phase N/A · The First Affiliated Hospital of Jiamusi University · The First Affiliated Hospital of Zhengzhou University · NCT06194968 TQB2930 Injection for the Treatment of HER2-positive Advanced Breast Cancer
Phase 3 · Jiamusi Tuberculosis Hospital (Jiamusi Tumor Hospital) · Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharm · NCT07047365 Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated S
Phase 3 · Jiamusi Cancer Hospital · BioNTech SE · NCT06712355 Preventive Drug-coated Balloon Angioplasty in Vulnerable Atherosclerotic Plaque (RESTORE Trial)
NA · The First Affiliated Hospital of Jiamusi University · Harbin Medical University · NCT06365502 Neurovascular Product Surveillance Registry
Phase N/A · First Affiliated Hospital of Jiamusi University · Medtronic Neurovascular Clinical Affairs · NCT02988128 A Study of BG-C477 in Participants With Advanced Solid Tumors
Phase 1 · Jiamusi Cancer Hospital · BeOne Medicines · NCT06596473 Art Therapy and Its Effect on Non-Motor Function Rehabilitation in the Subacute Phase of Stroke Recovery
NA · Fuyuan People's Hospital · Chonbuk National University · NCT06713252 D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell L
Phase 3 · Jiamusi Tuberculosis Hospital(Jiamusi Cancer Hospital) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06300177 Clinical Trial of TQB2102 for Injection Versus Trastuzumab Emtansine for Injection in HER2-positive Advanced Breast Canc
Phase 3 · Jiamusi Tuberculosis Hospital (Jiamusi Tumor Hospital) · Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharm · NCT07008976 A Study Testing How Well the Drug Extract of Ginkgo Biloba Leaves Tablets Works for People With Memory or Thinking Probl
Phase 4 · The First Affiliated Hospital of Jiamusi University · Dr. Willmar Schwabe GmbH & Co. KG · NCT07220538 A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-
Phase 3 · JIAMUSI TUBERCULOSIS HOSPITAL(CANCER HOSPITAL) ( Site 2745) · Merck Sharp & Dohme LLC · NCT07190248 A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung C
Phase 3 · JIAMUSI TUBERCULOSIS HOSPITAL(CANCER HOSPITAL) ( Site 3124) · Merck Sharp & Dohme LLC · NCT06345729

Look up another city

Look up another condition